Search

everythinglearnresearchcommunity

for

Search:↓

Stress and hormones like progesterone can affect absence seizures, but their effects change with different life stages.

Mutations in the P2RY5 gene cause hereditary woolly hair.

PRP and LLLT can improve hair growth in AGA, but more research needed.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

The method effectively detects banned substances in urine for sports antidoping.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Eating onions and garlic may have health benefits, but effects vary by type and preparation.

New drug shows promise for better hair growth in baldness treatment.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

The U.S. soybean industry wanted government help due to foreign competition, while the jojoba industry was growing and expected to stabilize.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

DNA profiling in forensics has improved, but predicting physical traits and ancestry from DNA has limitations and requires ethical consideration.

The Rotterdam Study aims to understand various diseases in older adults.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Paneth cells help support stem cells and aid tissue regeneration after injury.

Eczema and fungal infections are the most common skin problems in Japan, with different age groups and genders affected by various conditions.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Male pattern baldness involves hormones and cell signals affecting hair growth.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.